Orgenesis Inc. (ORGS) Social Stream
ORGENESIS INC (ORGS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ORGS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-14 | 1 | $9 | $9 | $9 | $0.462 | 1848.05% |
| 2023-03-22 | 1 | $6 | $6 | $6 | $0.462 | 1198.7% |
Price Target Last Issued March 22, 2023
The Trend in the Analyst Price Target
ORGS's average price target has moved down $3 over the prior 42 months.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-22 | 1 | 6 | 6 | 6 | 1.34 | 347.76% |
ORGS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORGS as an investment opportunity.
- In terms of how ORGENESIS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than nearly none of that group.
- ORGS has a lower variance in analysts' estimates than almost 100% of all US stocks.
- In the context of Healthcare stocks, ORGENESIS INC's upside potential (average analyst target price relative to current price) is greater than 182.81% of them.
- In terms of how ORGENESIS INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 24.07% of that group.
Stocks similar to ORGENESIS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EVOK, NBY, and SNOA.
View All Top Stocks by Price Target
Is ORGS a Buy, Hold or Sell? See the POWR Ratings now!